Pemetrexed is manufactured by Eli Lilly and Company for treating malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). The company has patented the drug as ‘Alimta,’ a vitamin regimen patent in the U.S. and Europe, which is valid up to 2022 and 2021 respectively. However, the patent for the compound in the U.S. and Europe has expired in January 2017 and December 2015, respectively.
Global pemetrexed market is segmented into application, end user, and region.
By application, the market is segmented into malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). Based on end user, the market is segmented into hospitals/clinics, oncology centers, offline pharmacies, online pharmacies, and others. The online pharmacies are expected to grow at the highest CAGR, owing to leaning trend towards online shopping and deals & offers by the e-commerce websites.
By geography, the global pemetrexed market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Got questions about your regional growth of
Just drop us a line or call on +1 646 480 7505
North America to dominate the global pemetrexed market owing to increasing demand for the drug in the region. Europe is expected to be the second largest market due to the significant presence of Eli Lilly, and Company in the region.
Asia Pacific is expected to be the fastest growing market for the pemetrexed as a result of the increasing number of patients suffering from lung cancer, high drug efficiency, and growing demand for chemotherapy for lung cancer treatment.
On the ground of poor healthcare infrastructure and sluggish technological advancement in the regions, Latin America and the Middle East & Africa are anticipated to account for least share of the market.
Eli Lilly and Company
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now